Cerebral venous thrombosis due to homozygous factor v Leiden mutation

Neurology India

Volumn 57, Issue 1, 2009, Pages 91-

  Aaron, S ^a   Alexander, M ^a   Thomas, M ^a   George, B ^a   Mammen, J ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; BLOOD CLOTTING FACTOR 5; HEPARIN;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GLASGOW COMA SCALE; HUMAN; LETTER; OCCLUSIVE CEREBROVASCULAR DISEASE; THROMBOPHLEBITIS;

BLOOD COAGULATION TESTS; BRAIN EDEMA; FACTOR V; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; PROTEIN C; VENOUS THROMBOSIS;

EID: 63449117175     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.48796     Document Type: Letter

References (6)

1. Bertina RM, Koeleman BP, Koiser T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in the blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
2. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-4.
3. Simioni P, Prandoni P, Lensing AW, Manfrin D, Tormene D, Gavasso S, et al. Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. Blood 2000;96:3329-33.
4. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344:1222-31.
5. Lüdemann P, Nabavi DG, Junker R, Wolff E, Papke K, Buchner H, et al. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: A case-control study of 55 patients. Stroke 1998;29:2507-10.
6. Szolnoki Z. Pathomechanism of leukoaraiosis: A molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis). Neuromolecular Med 2007;9:21-34.